BOARD OF DIRECTORS

Terrence Terifay

Terrence Terifay

QHP Capital Operating Advisor / Former Azurity Chief Commercial Officer – Global

As a QHP Capital Senior Executive Operating Advisor, Terrence offers over 30 years of experience in corporate strategy and build-out, general management, commercial operations, and organizational operations in private and publicly traded companies. Terrence was Chief Commercial Officer at Azurity Pharmaceuticals until August 2025, during a time of significant global expansion and overall performance growth. He led the transformation and expansion of the commercial organization through an innovative, industry leading go-to-market strategy that drives the value proposition for Azurity today. Prior to joining Azurity, he served as the Executive Vice President, Chief Commercial Officer for Charleston Laboratories, Inc., a specialty biopharmaceutical company focused on fixed dosed combination treatments for emesis related to acute conditions such as migraine and post-operative pain. He also served as Senior Vice President, Chief Commercial Officer for OptiNose, Inc., focused on drug-device combination treatments that optimize nasal drug delivery.

Prior to OptiNose, Terrence served in a range of U.S. and global leadership roles in publicly traded companies such as Covidien-Mallinckrodt, Cephalon, and Johnson & Johnson. He began his career at Janssen Pharmaceuticals, Inc.

Terrence has completed advanced leadership coursework from Washington University, St. Louis, MO and has dual degrees in Finance and Risk Management & Insurance from La Salle University in Philadelphia, PA.

Azurity Pharmaceuticals
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.